Esta investigación busca contribuir al conocimiento de las características de las interacciones mediadas por tecnologías entre adultos y niños en el contexto del Aislamiento Social, Preventivo y Obligatorio (ASPO) en Argentina, durante la pandemia provocada por COVID-19. En concreto, se propone estudiar si los contextos de interacción con tecnologías dan lugar a la producción narrativa infantil, qué características presentan las intervenciones de los adultos en relación con la construcción del relato y qué intervenciones adultas responden a las condiciones de la comunicación mediada por tecnologías. Con este propósito, se analizó un corpus de videograbaciones en el hogar que registra situaciones naturales en las que niños de entre 2 y 6 años utilizan dispositivos tecnológicos (Rosemberg et al., 2021). Los resultados evidencian que las situaciones que involucran el empleo de tecnologías representan oportunidades para la producción narrativa por parte de los niños. Además, coinciden con antecedentes que subrayan la relevancia que posee la participación contingente del adulto durante las interacciones con tecnologías para promover el desarrollo del lenguaje infantil. Específicamente, se destacan las estrategias discursivas de los adultos que apuntan a andamiar el desarrollo del relato infantil (reestructuran, expanden y reconceptualizan las emisiones infantiles, alientan a los niños a seguir narrando mediante comentarios evaluativos) y a sostener la interacción virtual (reparan fallas técnicas). Así, representa uno de los pocos estudios de nuestra región que brinda evidencia sobre la producción narrativa infantil mediada por tecnologías en el período de aislamiento por COVID-19 en Argentina, un contexto novedoso y desafiante.
Objective: Develop sterile vancomycin-amikacin reinforced antibiotics in smaller batches of finished products than those produced at the industrial level and under different working conditions. In this work, critical aspects concerning the elaboration process such as equipment and process evaluation, protocol development, physicochemical characterization, and microbiological tests were analyzed. In the first stage, the preparation of the formulations was carried out in the Department of Pharmaceutical Sciences of the Faculty of Chemical Sciences of the National University of Cordoba. In the second stage, the eye drops were prepared in the laboratory of Farmacia Vilarrubi, an office pharmacy authorized by the health authority and dedicated to the preparation of non-sterile compounding formulations. Both samples prepared at different manufacturing sites were subjected to the same physicochemical and microbiological tests. Methods and results:The sample compounding formulations of Vancomycin, Amikacin or their combination, at a dose of 30 mg/mL, were developed and subjected to physicochemical essays such as macroscopic observation, measurement of pH, osmolality, particle size, and quantification of drug concentration, during 7 days stored under adequate conditions of light and temperature. In addition, microbiological assays were carried out to verify their sterility and procedure under aseptic conditions. All the formulations made of reinforced antibiotic eye drops demonstrated high physicochemical and microbiological stability during the evaluated period. Conclusion:The reinforced antibiotic eye drops and the container used for their conservation showed correct sterility and microbiological stability during the time of use for the patient. It is possible to transfer small batch production of this type of quality sterile formulations to a pharmacy. For this, the training and education of the pharmaceutical professional is imperative.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.